Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study
Gerard Walls(Queen's University Belfast), Suneil Jain(Queen's University Belfast), Alan R. Hounsell(Belfast Health and Social Care Trust), David Johnston(Belfast Health and Social Care Trust), J. McAleese(Belfast Health and Social Care Trust), Valentina Giacometti(Queen's University Belfast), Conor K. McGarry(Belfast Health and Social Care Trust), Aidan Cole(Belfast Health and Social Care Trust), Éamon P McCarron(Salford Royal NHS Foundation Trust), Jayaraj Erekkath(Belfast Health and Social Care Trust), Karl T. Butterworth(Queen's University Belfast), Mark Harbinson(Belfast Health and Social Care Trust), Gerard G. Hanna(Belfast Health and Social Care Trust), Frances Duane(St. Luke's Hospital), Conor McCann(Belfast Health and Social Care Trust), Anna Gavin(Queen's University Belfast), John D. O’Connor(Queen's University Belfast), Peter McKavanagh(Ulster Hospital)
Cited by 29
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
|European Journal of Cancer|2021|650
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2019|643
Genomics of lethal prostate cancer at diagnosis and castration resistance
|Journal of Clinical Investigation|2019|303